Aeolus Pharmaceuticl
Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the… Read more
Aeolus Pharmaceuticl (AOLS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2017: -2.792x
Based on the latest financial reports, Aeolus Pharmaceuticl (AOLS) has a cash flow conversion efficiency ratio of -2.792x as of June 2017.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-578.00K) by net assets ($207.00K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Aeolus Pharmaceuticl - Cash Flow Conversion Efficiency Trend (1996–2016)
This chart illustrates how Aeolus Pharmaceuticl's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Aeolus Pharmaceuticl Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aeolus Pharmaceuticl ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cycurion, Inc. Common Stock
PINK:CYCU
|
-0.341x |
|
Arras Minerals Corp.
OTCQB:ARRKF
|
-0.064x |
|
D. M. Textile Mills Limited
KAR:DMTX
|
N/A |
|
Nowigence Inc.
OTCQB:NOWG
|
N/A |
|
Kegalle Plantations PLC
CM:KGALN0000
|
N/A |
|
SIEVI CAPITAL (WE3.SG)
STU:WE3
|
0.139x |
|
Bim Son Packing JSC
VN:BPC
|
N/A |
|
Union Andina de Cementos S.A.A.
LIM:UNACEMC1
|
N/A |
Annual Cash Flow Conversion Efficiency for Aeolus Pharmaceuticl (1996–2016)
The table below shows the annual cash flow conversion efficiency of Aeolus Pharmaceuticl from 1996 to 2016.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2016-09-30 | $3.19 Million | $-3.11 Million | -0.973x | -133.66% |
| 2015-09-30 | $-845.00K | $-2.44 Million | 2.891x | +1318.71% |
| 2014-09-30 | $1.58 Million | $323.00K | 0.204x | +104.84% |
| 2013-09-30 | $705.00K | $-2.97 Million | -4.213x | -9845.92% |
| 2012-09-30 | $-20.34 Million | $-879.00K | 0.043x | -67.59% |
| 2011-09-30 | $-23.26 Million | $-3.10 Million | 0.133x | +45.78% |
| 2010-09-30 | $-26.74 Million | $-2.45 Million | 0.091x | -94.50% |
| 2009-09-30 | $-1.16 Million | $-1.92 Million | 1.662x | -4.93% |
| 2008-09-30 | $-1.04 Million | $-1.81 Million | 1.748x | +167.00% |
| 2007-09-30 | $1.18 Million | $-3.08 Million | -2.609x | +8.48% |
| 2006-09-30 | $1.71 Million | $-4.87 Million | -2.851x | -138.84% |
| 2005-09-30 | $-932.00K | $-6.84 Million | 7.341x | +569.99% |
| 2004-09-30 | $5.53 Million | $-8.64 Million | -1.562x | -679.69% |
| 2003-09-30 | $-17.08 Million | $-4.60 Million | 0.269x | -54.41% |
| 2002-09-30 | $-14.48 Million | $-8.56 Million | 0.591x | +132.59% |
| 2001-09-30 | $5.65 Million | $-10.24 Million | -1.813x | +2.31% |
| 2000-09-30 | $4.81 Million | $-8.93 Million | -1.856x | +61.67% |
| 1999-09-30 | $3.80 Million | $-18.40 Million | -4.842x | -369.90% |
| 1998-09-30 | $19.70 Million | $-20.30 Million | -1.030x | -6726.78% |
| 1997-09-30 | $26.50 Million | $-400.00K | -0.015x | -146.42% |
| 1996-09-30 | $36.90 Million | $1.20 Million | 0.033x | -- |